Evidence map›Paper›PMID 40067616›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Isolation of Oligodendrocyte Precursor Cells with Immunomagnetic Beads for Their Better Viability In Vitro and In Vivo.

Paula Gómez-Martín, Alba Macías-Castellano, Beatriz Fernández-Gómez, Estefanía Sánchez-Jiménez, Miguel Marchena, Fernando de Castro

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paula Gómez-MartínGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.
Alba Macías-CastellanoGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.
Beatriz Fernández-GómezGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.
Estefanía Sánchez-JiménezGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.
Miguel MarchenaGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain.
Fernando de CastroGrupo de Neurobiología del Desarrollo-GNDe, Instituto Cajal-CSIC, Madrid, Spain. fdecastro@cajal.csic.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oligodendrocytes (OLs) are glial cells that myelinate axons in the central nervous system (CNS). These cells are generated from oligodendrocyte precursor cells (OPCs) during CNS development, and the population of OPCs that remain in the adult is responsible for spontaneous remyelination in demyelinating diseases such as multiple sclerosis (MS). Thus, OPCs represent an interesting source for regenerative therapies. Here, we describe an updated protocol for isolation of OPCs based on the magnetic cell separation (MACS) technology and oligodendroglial lineage-specific markers. After the extraction of nerve tissue, mechanical and enzymatic dissociation is performed. The cells are then immunomagnetically labeled and separated through columns composed of a matrix of ferromagnetic spheres coupled to the magnetic field of the MACS separator. This method has several advantages: it is significantly more efficient and faster if compared to other conventional methods, such as flow cytometry or shaking. In addition, the OPCs isolated in this way are significantly more viable, which facilitates their use of these cells in different experimental approaches, both in vitro and in vivo.

Indexed as

Cell SeparationImmunomagnetic SeparationOligodendrocyte Precursor CellsOligodendrogliaAnimalsCell DifferentiationCells, CulturedCell SurvivalMiceRatsA2B5Isolation protocolMACSMagnetic cell separation (MACS)MyelinNG2OPC

Identifiers

PMID40067616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.